Ainos (OTCMKTS:AIMD) Stock Price Down 1.9% – Here’s Why

Ainos, Inc. (OTCMKTS:AIMD) traded down 1.9% during mid-day trading on Friday . The company traded as low as $0.50 and last traded at $0.51. 38,478 shares changed hands during trading, a decline of 93% from the average session volume of 553,912 shares. The stock had previously closed at $0.52.

Ainos Trading Down 1.9 %

The company has a current ratio of 1.92, a quick ratio of 1.45 and a debt-to-equity ratio of 0.08. The firm has a 50-day moving average price of $0.60 and a 200-day moving average price of $0.53. The company has a market capitalization of $7.87 million, a price-to-earnings ratio of -0.59 and a beta of 1.51.

Ainos Company Profile

Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.